Mallory-Weiss lesion following cancer chemotherapy.
D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008309:Mallory-Weiss Syndrome / Q000139:chemically induced*; D008770:Methylnitrosourea / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D012673:Semustine / Q000009:adverse effects*; D014839:Vomiting / Q000139:chemically induced
D009607:Nitrosourea Compounds; D012673:Semustine; D008770:Methylnitrosourea; D005472:Fluorouracil